$10.840
-0.263 (-2.43%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de GLUE por análisis de gráficos similares
Alphio's GLUE stock price prediction model matches the current Monte Rosa Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.87 (+0.24%). The 1-week path is $11.32 (+4.44%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Monte Rosa Therapeutics Inc?
Monte Rosa Therapeutics Inc (GLUE) is a good buy right now due to its current price of $10.84, which is well below the average analyst price target of $25. The stock has shown a recent 5-day change of +11.29%, indicating positive momentum. However, the main risk is the negative earnings per share (EPS) estimate of -0.10 for the upcoming earnings report on November 5, 2026, which could impact investor sentiment.
GLUE cerró en $10.84 el Friday, tras bajar -2.43%
Monte Rosa Therapeutics Inc (GLUE) last closed at $10.84, losing -2.43%. These facts feed the 1-day and 1-week GLUE price prediction above.
Factores de la previsión
Los factores de la previsión de Monte Rosa Therapeutics Inc (GLUE) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de GLUE, ordenadas por similitud.
Análisis de estacionalidad de GLUE
Historically the probability of a positive October return for GLUE is 42.86%. November offers the highest probability of a positive month at 100.00%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de GLUE
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $2.74 | $6.63 | $7.74 | -38.82% |
| Nov 2026 | $8.46 | $10.53 | $12.50 | -2.88% |
| Dec 2026 | $7.18 | $10.32 | $14.75 | -4.79% |
En 2026, se proyecta que Monte Rosa Therapeutics Inc (GLUE) oscile entre $2.74 y $14.75.
Previsión mensual de Monte Rosa Therapeutics Inc para 2026
En Oct de 2026, se proyecta que Monte Rosa Therapeutics Inc promedie $6.63, con un mínimo de $2.74 y un máximo de $7.74.
En Nov de 2026, se proyecta que Monte Rosa Therapeutics Inc promedie $10.53, con un mínimo de $8.46 y un máximo de $12.50.
En Dec de 2026, se proyecta que Monte Rosa Therapeutics Inc promedie $10.32, con un mínimo de $7.18 y un máximo de $14.75.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.